Top Markets
Coin of the day
Hexima Limited Hexima Limited

Hexima Limited

HXL
Rang in Aktien #39775
Hexima Limited is a biotechnology firm focused on the discovery and advancement... Hexima Limited is a biotechnology firm focused on the discovery and advancement of plant-derived proteins and peptides for medical applications in humans. Its primary drug candidate, pezadeftide, a plant defensin, is presently undergoing Phase IIb clinical evaluations in Australia and New Zealand to address fungal toenail infections. The company was established in 1997 and its main operations are situated in Preston, Australia.
Aktienkurs
$0.0084929
Zuletzt synchronisiert: 2024-11-12
Marktkapitalisierung
$354.66K
Veränderung (1 Tag)
-0.64%
Veränderung (1 Jahr)
0.00%
Land
AU
Handel Hexima Limited (HXL)

Kategorie

Kursverlauf für Hexima Limited (HXL)
Höchster Schlusskurs: $0.01 am 2024-11-01

Niedrigster Schlusskurs: $1.03 am 2007-08-01
Kursverlauf der Aktie von Hexima Limited von 2007 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 -28.71%
2023 -7.17%
2022 -95.14%
2021 93.50%
2020 -60.31%
2011 -3.44%
2010 -18.73%
2009 75.03%
2008 -74.65%
2007 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$733.78 7.43%
CH
$1.07K -6.40%
KR
$259.89 14.81%
BE